Skyscape Web Viewer : The Maudsley Deprescribing Guidelines: Antidepressants, Benzodiazepines, Gabapentinoids and Z-drugs : Medication Index

View All
Tegretol
Temazepam Benzodiazepines Making Up Smaller Doses of Benzodiazepines and Z-Drugs Practically Solutions and suspensions Switching to Longer-Acting Benzodiazepines to Taper Tapering Temazepam When and Why to Stop Benzodiazepines and Z-Drugs When and Why to Stop Gabapentinoids Z drugs (benzodiazepine receptor agonists)
Tofranil
Tranxene
Tranylcypromine Antidepressants Factors Influencing Development of Withdrawal Effects Mis-Diagnosis of Withdrawal Effects As Relapse Phenelzine Recent Developments in the Understanding of Antidepressant Withdrawal Solutions and suspensions Tapering Tranylcypromine
Tranylcypromine Sulfate
Trazodone Antidepressants Dilutions Factors Influencing Development of Withdrawal Effects Managing Complications of Antidepressant Discontinuation Other Considerations in Tapering Benzodiazepines and Z-Drugs Practical Options in Prescribing Gradually Tapering Doses of Antidepressants Receptor occupancy, Solutions and suspensions Tapering Trazodone
Trazodone Hydrochloride
Triazolam Benzodiazepines Management of Complications of Benzodiazepine and Z-Drug Discontinuation Receptor occupancy, Solutions and suspensions Switching to Longer-Acting Benzodiazepines to Taper Tapering The Neurobiology of Tapering Triazolam Withdrawal Symptoms During Benzodiazepine Maintenance Treatment Z drugs (benzodiazepine receptor agonists)
Trimipramine Factors Influencing Development of Withdrawal Effects Stratfiying Risk of Antidepressant Withdrawal